Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled Phase IIb Trial of Inhaled N,N-Dimethyltryptamine (DMT) for Major Depressive Disorder

NCT07562191 is registered in ClinicalTrials.gov with Universidade Federal do Rio Grande do Norte as lead sponsor.

NCT NCT07562191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07562191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled Phase IIb Trial of Inhaled N,N-Dimethyltryptamine (DMT) for Major Depressive Disorder
Lead sponsor
Universidade Federal do Rio Grande do Norte
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2026
Completion date
August 1, 2027
Enrollment
140 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, major depressive disorder (mdd), mdd, suicidal ideation, suicide